Call Us: 1 (800) 647 6100
6900 Kingspointe Pkwy, Orlando, FL 32819, US
Open in Google Maps
6900 Kingspointe Pkwy, Orlando, FL 32819, US
This one-day conference will focus on successful clinical interventions for Lyme Disease and various complex childhood disorders. Two pioneers in their respective fields will present cutting-edge research, case studies, integrative strategies and nutritional protocols for managing and healing these new epidemics.
Series Dates | Locations | Pricing
Understand the prevalence and symptoms associated with Lyme disease and multiple systemic infectious disease syndrome (MSIDS)
Utilize Dr. Horowitz’s 16-point MSIDS map in the diagnosis and treatment of Lyme disease, associated co-infections and chronic disease
Expand your assessment techniques with a 38-point survey that corresponds to lab blood work
Be able to identify the roles of detoxification and the 3Is (infection, inflammation, and immunity) in Lyme disease and chronic, persistent illnesses
Learn about integrative and nutritional protocols that you can incorporate into your practice
Richard Horowitz, MD, is a board-certified internist in private practice in Hyde Park, NY. He is the medical director of the Hudson Valley Healing Arts Center, an integrative medical center that combines classical and complementary approaches in the treatment of Lyme disease and other tick-borne disorders. Dr. Horowitz has treated over 12,000 chronic Lyme disease patients and is former president-elect of the International Lyme and Associated Diseases Society (ILADS). In his NY Times Best Selling book Why Can't I Get Better? Solving the Mystery of Lyme and Chronic Disease, he explains his full diagnostic and treatment approach to patients who have complex tick-borne illnesses. His upcoming book How Can I Get Better? An Action Plan for Treating Resistant Lyme and Chronic Disease will be released in November of 2016. Dr. Horowitz is an esteemed member of the XYMOGEN Board of Advisors.
Recent studies suggest that the number of people diagnosed with Lyme disease each year in the United States is approximately 300,0001
In 2012, approximately 1 in 45 American children had been identified with autism spectrum disorder (ASD), up from 1 in 150 in the year 20002
Approximately 1 percent of the world's population has been identified with autism spectrum disorder (ASD)3
More than 80 countries have reported cases of Lyme disease4
The prevalence of ADHD is at least as high in many other countries as it is in the United States5
An estimated 300 million people suffer from asthma, with 250,000 annual deaths attributed to the disease6
Identify pathogenesis, clinical presentations and commonalities of these various childhood disorders
Explore pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute neuropsychiatric syndrome (PANS)
Discover the links between oxidative stress, cytokine imbalance and environmental toxins (such as pollution, pesticides, heavy metals and other chemicals) in the 4As
Gain knowledge about the neuroimmune system: interrelationships between the immune system, the nervous system, and the gut
Grasp the concept of integrative treatment and nutritional protocols utilizing hands-on approaches and case studies
Kenneth Bock, MD, FAAFP, FACN, CNS, received his MD with honors from the University of Rochester School of Medicine and Dentistry in 1979. Dr. Bock is the founder of Bock Integrative Medicine in Red Hook, NY, and has been a pioneer and leader in the field of integrative medicine for over three decades. Dr. Bock is a popular national and international speaker at major med-ical conferences and has appeared on various radio and television shows. He is a faculty member of the Institute for Functional Medicine (IFM) and taught in its Advanced Detox Module. Dr. Bock is the co-author of The Road to Immunity and Natural Re-lief for Your Child's Asthma. His latest book, Healing the New Childhood Epidemics: Autism, ADHD, Asthma, and Allergies, has received international acclaim. Dr. Bock is an esteemed member of the XYMOGEN Board of Advisors.
*Early Bird registration must be made one month prior to the event date.
**Super Early Bird registration must be made two months prior to event date.
†The Oct. 22, 2016 date in Denver, Colorado is part of The Denver Summit event. Registration cost for this date will vary from that mentioned above. For more information about this date, location, additional speakers and cost please visit www.thedenversummit.com
For additional information from our featured presenters regarding the integrative approaches covered in this event series, we recommend reading their books. Get your copies today, available at Barnes & Noble and Amazon.com.
We at XYMOGEN, are committed to respecting your online privacy and recognize your need for appropriate protection and management of any personally identifiable information ("Personal Information") you share with us.
Personal Information means any information that may be used to identify an individual, including, but not limited to, a first and last name, a home or other physical address and an email address or other contact information, whether at work or at home. In general, you can visit XYMOGEN's Web pages without telling us who you are or revealing any Personal Information about yourself.
If you choose to provide us with your Personal Information on the Web, we may transfer that Information within XYMOGEN or to XYMOGEN's third-party service providers, across borders, and from your country or jurisdiction to other countries or jurisdictions around the world.
Where XYMOGEN collects Personal Information on the web, we intend to post a purpose statement that explains why Personal Information will be collected and whether we plan to share such Personal Information outside of XYMOGEN or those working on XYMOGEN's behalf. XYMOGEN does not intend to transfer Personal Information without your consent to third parties who are not bound to act on XYMOGEN's behalf unless such transfer is legally required.
You may choose whether or not to provide Personal Information to XYMOGEN. The notice we intend to provide where XYMOGEN collects Personal Information on the Web should help you to make this choice. If you choose not to provide the Personal Information we request, you can still visit most of XYMOGEN's Web sites, but you may be unable to access certain options, offers, and services that involve our interaction with you.
If you chose to have a relationship with XYMOGEN, such as a contractual or other business relationship or partnership, we will naturally continue to contact you in connection with that business relationship.
Wherever your Personal Information may be held within XYMOGEN or on its behalf, we intend to take reasonable and appropriate steps to protect the Personal Information that you share with us from unauthorized access or disclosure.
To the extent that you do provide us with Personal Information, XYMOGEN wishes to maintain accurate Personal Information. Where we collect Personal Information from you on the Web, our goal is to provide a means of contacting XYMOGEN should you need to update or correct that Information. If for any reason those means are unavailable or inaccessible, you may send updates and corrections about your Personal Information to privacy@XYMOGEN.com and we will make reasonable efforts to incorporate the changes in your Personal Information that we hold as soon as practicable.
Third parties provide certain services available on XYMOGEN.com on XYMOGEN's behalf. XYMOGEN may provide information, including Personal Information, that XYMOGEN collects on the Web to third-party service providers to help us deliver programs, products, information, and services. Service providers are also an important means by which XYMOGEN maintains its Web site and mailing lists. XYMOGEN will take reasonable steps to ensure that these third-party service providers are obligated to protect Personal Information on XYMOGEN's behalf.
XYMOGEN does not intend to transfer Personal Information without your consent to third parties who are not bound to act on XYMOGEN's behalf unless such transfer is legally required. Similarly, it is against XYMOGEN's policy to sell Personal Information collected online without consent.
XYMOGEN.com is not structured to attract children. Accordingly, we do not intend to collect Personal Information from anyone we know to be under 13 years of age.
We are committed to privacy and, through our membership in the Online Privacy Alliance, are actively involved in and support current industry initiatives to preserve individual privacy rights on the Internet. Protecting your privacy online is an evolving area, and XYMOGEN's Web sites are constantly evolving to meet these demands.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.